Efficacy of Concomitant Elemental Diet Therapy in Scheduled Infliximab Therapy in Patients with Crohn’s Disease to Prevent Loss of Response

被引：0
|
作者：
Noriko Kamata
Nobuhide Oshitani
Kenji Watanabe
Kimihiko Watanabe
Shuhei Hosomi
Atsushi Noguchi
Tomomi Yukawa
Hirokazu Yamagami
Matsatsugu Shiba
Tetsuya Tanigawa
Toshio Watanabe
Kazunari Tominaga
Yasuhiro Fujiwara
Tetsuo Arakawa
机构：
[1] Osaka City University Graduate School of Medicine,Department of Gastroenterology
[2] Aizeznbashi Hospital,Department of Medicine, Social Welfare Service Corporation, Ishii Memorial Aizen
[3] Osaka City General Hospital,en
来源：
Digestive Diseases and Sciences | 2015年 / 60卷
关键词：
Crohn’s disease; Infliximab; Loss of response; Elemental diet;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1382 / 1388
页数：6
相关论文
共 50 条
  • [1] Efficacy of Concomitant Elemental Diet Therapy in Scheduled Infliximab Therapy in Patients with Crohn's Disease to Prevent Loss of Response
    Kamata, Noriko
    Oshitani, Nobuhide
    Watanabe, Kenji
    Watanabe, Kimihiko
    Hosomi, Shuhei
    Noguchi, Atsushi
    Yukawa, Tomomi
    Yamagami, Hirokazu
    Shiba, Matsatsugu
    Tanigawa, Tetsuya
    Watanabe, Toshio
    Tominaga, Kazunari
    Fujiwara, Yasuhiro
    Arakawa, Tetsuo
    DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (05) : 1382 - 1388
  • [2] Concomitant Elemental Diet Therapy Is Effective in Sustaining Infliximab Scheduled Maintenance Therapy in Patients With Crohn's Disease to Prevent Loss of Response
    Kamata, Noriko
    Watanabe, Kenji
    Tsukahara, Takuya
    Hagihara, Yoshie
    Morimoto, Kenichi
    Noguchi, Atsushi
    Miyazaki, Takako
    Sogawa, Mitsue
    Yamagami, Hirokazu
    Tanigawa, Tetsuya
    Shiba, Masatsugu
    Watanabe, Toshio
    Tominaga, Kazunari
    Fujiwara, Yasuhiro
    Arakawa, Tetsuo
    GASTROENTEROLOGY, 2013, 144 (05) : S433 - S433
  • [3] Efficacy of a concomitant elemental diet to reduce the loss of response to adalimumab in patients with intractable Crohn's disease
    Sugita, Naoko
    Watanabe, Kenji
    Kamata, Noriko
    Yukawa, Tomomi
    Otani, Koji
    Hosomi, Shuhei
    Nagami, Yasuaki
    Tanaka, Fumio
    Taira, Koichi
    Yamagami, Hirokazu
    Tanigawa, Tetsuya
    Shiba, Masatsugu
    Watanabe, Toshio
    Tominaga, Kazunari
    Kabata, Daijiro
    Shintani, Ayumi
    Arakawa, Tetsuo
    Fujiwara, Yasuhiro
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (03) : 631 - 637
  • [4] Loss of response to scheduled infliximab therapy for Crohn's disease in adults: A systematic review and meta-analysis
    Zhang, Qi Wei
    Shen, Jun
    Zheng, Qing
    Ran, Zhi Hua
    JOURNAL OF DIGESTIVE DISEASES, 2019, 20 (02) : 65 - 72
  • [5] Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial
    Hisamatsu, Tadakazu
    Kunisaki, Reiko
    Nakamura, Shiro
    Tsujikawa, Tomoyuki
    Hirai, Fumihito
    Nakase, Hiroshi
    Watanabe, Kenji
    Yokoyama, Kaoru
    Nagahori, Masakazu
    Kanai, Takanori
    Naganuma, Makoto
    Michimae, Hirofumi
    Andoh, Akira
    Yamada, Akihiro
    Yokoyama, Tadashi
    Kamata, Noriko
    Tanaka, Shinji
    Suzuki, Yasuo
    Hibi, Toshifumi
    Watanabe, Mamoru
    INTESTINAL RESEARCH, 2018, 16 (03) : 494 - +
  • [6] What Is the Rate of Loss of Response to Infliximab Therapy in Crohn's Disease?
    Chao, Jingdong
    Mulani, Parvez
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (09): : 2353 - 2354
  • [7] What Is the Rate of Loss of Response to Infliximab Therapy in Crohn's Disease? Response
    Gisbert, Javier P.
    Panes, Julian
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (09): : 2354 - 2355
  • [8] Concomitant Use of Enteral Nutrition Therapy Increases Sustained Response to Infliximab in Patients With Crohn's Disease
    Sakurai, Takehiro
    Yoshihama, Sayuri
    Katsuno, Tatsuro
    Saito, Keiko
    Minemura, Shoko
    Maruoka, Daisuke
    Matsumura, Tomoaki
    Nakagawa, Tomoo
    Arai, Makoto
    Yokosuka, Osamu
    GASTROENTEROLOGY, 2015, 148 (04) : S249 - S249
  • [9] Concomitant use of enteral nutrition therapy is associated with sustained response to infliximab in patients with Crohn's disease
    Sazuka, S.
    Katsuno, T.
    Nakagawa, T.
    Saito, M.
    Saito, K.
    Matsumura, T.
    Arai, M.
    Sato, T.
    Yokosuka, O.
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2012, 66 (11) : 1219 - 1223
  • [10] Concomitant use of enteral nutrition therapy is associated with sustained response to infliximab in patients with Crohn’s disease
    S Sazuka
    T Katsuno
    T Nakagawa
    M Saito
    K Saito
    T Matsumura
    M Arai
    T Sato
    O Yokosuka
    European Journal of Clinical Nutrition, 2012, 66 : 1219 - 1223
12345